Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02249325 · ClinicalTrials.gov registry record · NA
Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization
A NA study, sponsored by Marquette University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02249325 is a NA study that has completed, run by Marquette University. The registered enrollment target is 20 participants.
The verdict
NCT02249325, a NA study, has completed, sponsored by Marquette University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This pilot quasi experiment was designed to determine the feasibility of a randomized controlled trial of the oral probiotic combination of Florajen3 (\>7.5 x109 L. acidophilus, \>6.0 x109. B. lactis, and \>1.5 x109 B. longum) taken orally once daily beginning at 28 weeks gestation, against placebo, to reduce the colonization of group B Streptococcus at 36 weeks.
Interventions
- DIETARY_SUPPLEMENT Probiotic dietary supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02249325
The ClinicalTrials.gov registry entry for NCT02249325 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Marquette University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Probiotic dietary supplement is the first listed.
NCT02249325 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02249325 about?
NCT02249325 is a clinical study titled "Quasi Experiment of Prenatal Probiotics Against Group B Streptococcus Colonization". This pilot quasi experiment was designed to determine the feasibility of a randomized controlled trial of the oral probiotic combination of Florajen3 (\>7.5 x109 L. acidophilus, \>6.0 x109. B. lactis, and \>1.5 x109 B. longum) taken orally once daily beginning at 28 weeks gestation, against placebo,...
What is the current status of trial NCT02249325?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2013-06.
What interventions are being tested in trial NCT02249325?
The interventions under investigation include: Probiotic dietary supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02249325?
This trial is sponsored by Marquette University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.